Literature DB >> 10813276

A histochemical study of the rheumatoid synovium: focus on nitric oxide, nerve growth factor high affinity receptor, and innervation.

M Pozza1, M Guerra, E Manzini, L Calza.   

Abstract

OBJECTIVE: The synovium of patients with rheumatoid arthritis (RA) is characterized by massive cell proliferation, neoangiogenesis, and apoptosis. The nature of potential repressors/inducers of these phenomena is still largely unknown. We investigate if nitric oxide (NO) and nerve growth factor (NGF) can be considered potential mediators in these phenomena in RA.
METHODS: Synovium of 15 patients with RA in active phase and synovium of 14 patients without synovial inflammation were processed for histochemical (NADPH-diaphorase) and immunohistochemical visualization of different isoforms for the NO synthesis enzyme NO synthase (NOS) and for NGF high affinity receptor trkA.
RESULTS: Inducible NOS (iNOS) immunoreactivity and NADPH-diaphorase positivity were found in synoviocytes, fibroblast-like synoviocytes, fibroblasts, and inflammatory cells in the rheumatoid synovium. In the same areas and in the same cell types, although not in the same cells, we also found positivity for the NGF high affinity receptor trkA.
CONCLUSION: We suggest that all elements involved in the transduction pathway that is activated by NGF and that proceeds through NO and tumor suppressor p53 are present in the synovium during RA, controlling cell cycle arrest, cell differentiation, and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813276

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment.

Authors:  M Rihl; E Kruithof; C Barthel; F De Keyser; E M Veys; H Zeidler; D T Y Yu; J G Kuipers; D Baeten
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

2.  Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors.

Authors:  L Calza; L Giardino; A Giuliani; L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

3.  Inducible nitric oxide synthase is expressed in synovial fluid granulocytes.

Authors:  J Cedergren; T Forslund; T Sundqvist; T Skogh
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

4.  UDP-glucose dehydrogenase (UGDH) activity is suppressed by peroxide and promoted by PDGF in fibroblast-like synoviocytes: Evidence of a redox control mechanism.

Authors:  Ramya Chandrasekaran; Colleen Mathieu; Rishi Sheth; Alexandre P Cheng; David Fong; Robert McCormack; Hani El-Gabalawy; Suman Alishetty; Mikell Paige; Caroline D Hoemann
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

5.  Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis.

Authors:  Christian Barthel; Nataliya Yeremenko; Roland Jacobs; Reinhold E Schmidt; Michael Bernateck; Henning Zeidler; Paul-Peter Tak; Dominique Baeten; Markus Rihl
Journal:  Arthritis Res Ther       Date:  2009-06-02       Impact factor: 5.156

6.  Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis.

Authors:  Sadaf Ashraf; Paul Ian Mapp; James Burston; Andrew John Bennett; Victoria Chapman; David Andrew Walsh
Journal:  Ann Rheum Dis       Date:  2013-07-13       Impact factor: 19.103

7.  The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue.

Authors:  Joana R F Abreu; Daphne de Launay; Marjolein E Sanders; Aleksander M Grabiec; Marleen G van de Sande; Paul P Tak; Kris A Reedquist
Journal:  Arthritis Res Ther       Date:  2009-08-13       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.